(Q48966295)

17 February 2018

title

The albumin in acute stroke trial (ALIAS); design and methodology. (English)

1 reference

17 February 2018

Michael D Hill

1

0 references

author name string

Claudia S Moy

2

1 reference

17 February 2018

Yuko Y Palesch

3

1 reference

17 February 2018

Renee Martin

4

1 reference

17 February 2018

Catherine R Dillon

5

1 reference

17 February 2018

Bonnie Darcy Waldman

6

1 reference

17 February 2018

Lynn Patterson

7

1 reference

17 February 2018

Isabel M Mendez

8

1 reference

17 February 2018

Karla J Ryckborst

9

1 reference

17 February 2018

Diego Tamariz

10

1 reference

17 February 2018

Myron D Ginsberg

11

1 reference

17 February 2018

ALIAS Investigators

12

1 reference

17 February 2018

publication date

1 August 2007

1 reference

17 February 2018

International Journal of Stroke

published in

1 reference

17 February 2018

volume

2

1 reference

17 February 2018

issue

3

1 reference

17 February 2018

page(s)

214-219

1 reference

17 February 2018

Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2007.00143.X

Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2007.00143.X

Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2007.00143.X

Neuroprotective effect of treatment with human albumin in permanent focal cerebral ischemia: histopathology and cortical perfusion studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2007.00143.X

Posttreatment with high-dose albumin reduces histopathological damage and improves neurological deficit following fluid percussion brain injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2007.00143.X

The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2007.00143.X

Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2007.00143.X

Systemic fatty acid responses to transient focal cerebral ischemia: influence of neuroprotectant therapy with human albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2007.00143.X

The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2007.00143.X

The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2007.00143.X

Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2007.00143.X

Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2007.00143.X

NXY-059 for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2007.00143.X

Stroke and neurovascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2007.00143.X

A Multiple Testing Procedure for Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2007.00143.X

The ALIAS (ALbumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and progress report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2007.00143.X

10.1111/J.1747-4949.2007.00143.X

21 January 2018

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018